%0 Journal Article
%T Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
%A Alberto Martini
%A Anasuya Hazra
%A Charles A. Mebus
%A Christine Alvey
%A Daniel J. Kingsbury
%A Daniel J. Lovell
%A Elzbieta Smolewska
%A Gerd Horneff
%A Hermine I. Brunner
%A Ivan Foeldvari
%A Manisha Lamba
%A Min Wang
%A Nicolino Ruperto
%A Nikolay Tzaribachev
%A Ricardo Suehiro
%A Richard K. Vehe
%A Rong Wang
%A Sriram Krishnaswami
%A Thomas C. Stock
%A Zbigniew Zuber
%A for the Pediatric Rheumatology International Trials Organization (PRINTO)
%A the Pediatric Rheumatology Collaborative Study Group (PRCSG)
%J Archive of "Pediatric Rheumatology Online Journal".
%D 2017
%R 10.1186/s12969-017-0212-y
%X The online version of this article (10.1186/s12969-017-0212-y) contains supplementary material, which is available to authorized users
%K Janus kinase inhibitor
%K Juvenile idiopathic arthritis
%K Tofacitinib
%K Pediatric
%K Pharmacokinetics
%K Safety
%K Dosing
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745974/